Miao, Lei
Li, Linxian
Huang, Yuxuan
Delcassian, Derfogail http://orcid.org/0000-0002-8030-7672
Chahal, Jasdave
Han, Jinsong http://orcid.org/0000-0003-1832-2641
Shi, Yunhua
Sadtler, Kaitlyn http://orcid.org/0000-0003-2587-8330
Gao, Wenting
Lin, Jiaqi
Doloff, Joshua C. http://orcid.org/0000-0002-4323-3264
Langer, Robert
Anderson, Daniel G.
Article History
Received: 15 August 2018
Revised: 13 July 2019
Accepted: 29 July 2019
First Online: 30 September 2019
Competing interests
: L.M., Y.H., L.L. and D.G.A. have filed a patent for the development of the described lipids synthesized using the three-component reaction. R.L. receives licensing fees (to patents in which he was an inventor on) from, invested in, consults (or was on scientific advisory boards or boards of directors) for, lectured (and received a fee), or conducts sponsored research at MIT for which he was not paid for the following entities: 7th Sense, Abpro, Aleph Farms, Alkermes, Allevi, Alnylam, Artificial Cells, Arsenal Medical, BASF, Celero, Cellomics, Cellular Biomedical, Clarus, Clontech, Combined Therapeutics, Conference Forum, Curis, Domain, Eagle, Echo, Edge, Evox, Fate Therapeutics, Frequency Therapeutics, Genscript, Glycobia, Glympse, Grandhope, Greenlight, HKF Technologies, Horizon Discovery, Humacyte, Indivor, Inovio, Institute of Immunology, In Vivo Therapeutics, Ironwood Pharmaceuticals, Kallyope, Kensa, Keratinx, KSQ Therapeutics, Laderatech, Inc., Landsdowne Labs, Like Minds, Luminopia, Luye, Lyndra, Lyra, Medical Kinetics, Merck, Micelle, Moderna, Momenta, Monsanto, Mylan, Nanobiosym, Nanobiotix, Noveome, Particles for Humanity, Perosphere, Pfizer, Polaris, Portal, Pulmatrix, Puretech, Roche, Rubius, Secant, Selecta Biosciences, Setsuro, Shiseido, Sigilon, Sio2, SQZ, Stembiosys, Suono Bio, T2 Biosystems, Tara, Taris Biomedical, Tarveda, Third Rock, Tiba, Tissium, Titan Pharma, Unilever, VasoRX, Verseau Therapeutics, Vivtex, Wiki Foods and Zenomic.